Abstract
A WHO rapid assessment of early impact of the COVID-19 pandemic on mental health services worldwide found a consistent pattern of degradation. In this context the MASC study aimed to: identify the consequences of the pandemic for mental health services and people with pre- existing mental health conditions (MHCs) in 7 low- and middle-income countries; and (2) identify good practice to mitigate these impacts. The study was conducted in Chile, Ethiopia, Georgia, Nigeria, South Africa, Sri Lanka and Ukraine. This was an observational study, using a mixed- methods convergent design, triangulating data from: (1) 144 key informants participating in semi- structured interviews or focus groups and/or a self-completed survey; (2) routine service utilization data; (3) local grey literature; and (4) expert consultation. We found clear evidence in all sites that the pandemic exacerbated pre-existing disadvantages experienced by people with MHCs and led to a deterioration in the availability and quality of care, especially for psychosocial care. Alongside increased vulnerability to COVID-19, people with MHCs faced additional barriers to accessing prevention and treatment interventions compared to the general population. To varying extents, sites showed accelerated implementation of digital technologies, but with evidence of worsening inequities in access. Where primary care-based mental health care was more developed or prioritised, systems seemed more resilient and adaptive. Our findings have the following implications. First, mental health service reductions are clear examples of ‘structural stigma’, namely policy level decisions in healthcare which place a low priority upon services for people with MHCs. Second, integration of mental health care into all general health care settings is key to ensuring accessibility and parity of physical and mental health care. Third, digital innovations should be designed to strengthen and not fragment systems. We discuss these findings in terms of anticipating such challenges in future and preparing layers of resilience.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The author(s) received no specific funding for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approval was obtained from King’s College London Research Ethics Committee (HR-20/21-21056) and from each participating country partner: Chile: Institutional Review Board of the Faculty of Medicine of the University of Chile (project No. 270-2020) Ethiopia: Institutional Review Board of the College of Health Sciences, Addis Ababa University (Ref 087/20/CDT) Georgia (Ethics Committee at Ilia State University Ref. N 037-102020) Nigeria: University of Ibadan/University College Hospital Ethics Committee (UI/EC/20/0366) South Africa: University of Cape Town Human Ethics Research Council (Ref: 552/2020) Sri Lanka: Rajarata University of Sri Lanka Ethics Review Committee (ERC/2021/06) Ukraine: Ethics committee of Taras Shevchenko National University of Kyiv’s Institute of Psychiatry (No. 2/10/01/2022).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
Quantitative data on service utilisation are included within supplementary information file 4. Qualitative and narrative data cannot be fully anonymised and made publicly available given the small number of key informants in each country. The data underlying the findings can be obtained from the authors on request.
